{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:17:14Z","timestamp":1762867034806,"version":"3.37.3"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12944-017-0430-9","type":"journal-article","created":{"date-parts":[[2017,2,7]],"date-time":"2017-02-07T09:43:10Z","timestamp":1486460590000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["The potential role of mitochondrial ATP synthase inhibitory factor 1 (IF1) in coronary heart disease: a literature review"],"prefix":"10.1186","volume":"16","author":[{"given":"Serban","family":"Maierean","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria-Corina","family":"Serban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manfredi","family":"Rizzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Lippi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amirhossein","family":"Sahebkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6690-6874","authenticated-orcid":false,"given":"Maciej","family":"Banach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,2,7]]},"reference":[{"key":"430_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12916-016-0550-5","volume":"14","author":"FD Hobbs","year":"2016","unstructured":"Hobbs FD, et al. Is statin-modified reduction in lipids the most important preventive therapy for cardiovascular disease? a pro\/con debate. BMC Med. 2016;14:1\u20138. doi: 10.1186\/s12916-016-0550-5 .","journal-title":"BMC Med"},{"issue":"9","key":"430_CR2","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1097\/HJH.0b013e3283569a9c","volume":"30","author":"A Gluba","year":"2012","unstructured":"Gluba A, et al. An update on biomarkers of heart failure in hypertensive patients. J Hypertens. 2012;30(9):1681\u20139. doi: 10.1097\/HJH.0b013e3283569a9c .","journal-title":"J Hypertens"},{"key":"430_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12944-015-0169-0","volume":"14","author":"M Banach","year":"2015","unstructured":"Banach M, et al. Lipids, blood pressure and kidney update 2015. Lipids Health Dis. 2015;14:1\u201314. doi: 10.1186\/s12944-015-0169-0 .","journal-title":"Lipids Health Dis"},{"key":"430_CR4","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1146\/annurev.micro.50.1.791","volume":"50","author":"G Deckers-Hebestreit","year":"1996","unstructured":"Deckers-Hebestreit G, Altendorf K. The F0F1-type ATP synthases of bacteria: structure and function of the F0 complex. Annu Rev Microbiol. 1996;50:791\u2013824. doi: 10.1146\/annurev.micro.50.1.791 .","journal-title":"Annu Rev Microbiol"},{"issue":"11","key":"430_CR5","doi-asserted-by":"publisher","first-page":"2810","DOI":"10.1161\/01.CIR.91.11.2810","volume":"91","author":"K Vuorinen","year":"1995","unstructured":"Vuorinen K, et al. Mechanisms of ischemic preconditioning in rat myocardium. Roles of adenosine, cellular energy state, and mitochondrial F1F0-ATPase. Circulation. 1995;91(11):2810\u20138. doi: 10.1161\/01.CIR.91.11.2810 .","journal-title":"Circulation"},{"issue":"39","key":"430_CR6","doi-asserted-by":"publisher","first-page":"23638","DOI":"10.1074\/jbc.271.39.23638","volume":"271","author":"W Rouslin","year":"1996","unstructured":"Rouslin W, Broge CW. IF1 function in situ in uncoupler-challenged ischemic rabbit, rat, and pigeon hearts. J Biol Chem. 1996;271(39):23638\u201341. doi: 10.1074\/jbc.271.39.23638 .","journal-title":"J Biol Chem"},{"issue":"1\u20132","key":"430_CR7","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1023\/A:1006818708565","volume":"184","author":"IE Hassinen","year":"1998","unstructured":"Hassinen IE, et al. Role of cellular energetics in ischemia-reperfusion and ischemic preconditioning of myocardium. Mol Cell Biochem. 1998;184(1\u20132):393\u2013400. doi: 10.1023\/A:1006818708565 .","journal-title":"Mol Cell Biochem"},{"issue":"1","key":"430_CR8","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.cmet.2008.06.001","volume":"8","author":"M Campanella","year":"2008","unstructured":"Campanella M, et al. Regulation of mitochondrial structure and function by the F1Fo-ATPase inhibitor protein, IF1. Cell Metab. 2008;8(1):13\u201325. doi: 10.1016\/j.cmet.2008.06.001 .","journal-title":"Cell Metab"},{"issue":"Pt 2","key":"430_CR9","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1042\/bj3240635","volume":"324","author":"J Ricart","year":"1997","unstructured":"Ricart J, et al. Subcellular structure containing mRNA for beta subunit of mitochondrial H\u2009+\u2009\u2212ATP synthase in rat hepatocytes is translationally active. Biochem J. 1997;324(Pt 2):635\u201343. doi: 10.1042\/bj3240635 .","journal-title":"Biochem J"},{"issue":"6918","key":"430_CR10","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/nature01250","volume":"421","author":"LO Martinez","year":"2003","unstructured":"Martinez LO, et al. Ectopic beta-chain of ATP synthase is an apolipoprotein A-I receptor in hepatic HDL endocytosis. Nature. 2003;421(6918):75\u20139. doi: 10.1038\/nature01250 .","journal-title":"Nature"},{"issue":"9","key":"430_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0023949","volume":"6","author":"A Genoux","year":"2011","unstructured":"Genoux A, et al. Mitochondrial inhibitory factor 1 (IF1) is present in human serum and is positively correlated with HDL-cholesterol. Plos One. 2011;6(9):1\u20138. doi: 10.1371\/journal.pone.0023949 .","journal-title":"Plos One"},{"issue":"9","key":"430_CR12","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.1194\/jlr.P036335","volume":"54","author":"A Genoux","year":"2013","unstructured":"Genoux A, et al. Serum IF1 concentration is independently associated to HDL levels and to coronary heart disease: the GENES study. J Lipid Res. 2013;54(9):2550\u20138. doi: 10.1194\/jlr.P036335 .","journal-title":"J Lipid Res"},{"issue":"1","key":"430_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12916-016-0672-9","volume":"14","author":"A Genoux","year":"2016","unstructured":"Genoux A, et al. Serum levels of mitochondrial inhibitory factor 1 are independently associated with long-term prognosis in coronary artery disease: the GENES study. BMC Med. 2016;14(1):1\u201310. doi: 10.1186\/s12916-016-0672-9 .","journal-title":"BMC Med"},{"issue":"5","key":"430_CR14","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1002\/hep.27312","volume":"60","author":"R Song","year":"2014","unstructured":"Song R, et al. Reciprocal activation between ATPase inhibitory factor 1 and NF-kappaB drives hepatocellular carcinoma angiogenesis and metastasis. Hepatology. 2014;60(5):1659\u201373. doi: 10.1002\/hep.27312 .","journal-title":"Hepatology"},{"issue":"3","key":"430_CR15","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1074\/jbc.M405947200","volume":"280","author":"NR Burwick","year":"2005","unstructured":"Burwick NR, et al. An Inhibitor of the F1 subunit of ATP synthase (IF1) modulates the activity of angiostatin on the endothelial cell surface. J Biol Chem. 2005;280(3):1740\u20135. doi: 10.1074\/jbc.M405947200 .","journal-title":"J Biol Chem"},{"key":"430_CR16","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.mvr.2014.11.003","volume":"98","author":"V Gonzalez-Pecchi","year":"2015","unstructured":"Gonzalez-Pecchi V, et al. Apolipoprotein A-I enhances proliferation of human endothelial progenitor cells and promotes angiogenesis through the cell surface ATP synthase. Microvasc Res. 2015;98:9\u201315. doi: 10.1016\/j.mvr.2014.11.003 .","journal-title":"Microvasc Res"},{"issue":"5","key":"430_CR17","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1093\/eurheartj\/ehr308","volume":"33","author":"P Meier","year":"2012","unstructured":"Meier P, et al. The impact of the coronary collateral circulation on mortality: a meta-analysis. Eur Heart J. 2012;33(5):614\u201321. doi: 10.1093\/eurheartj\/ehr308 .","journal-title":"Eur Heart J"},{"issue":"22","key":"430_CR18","doi-asserted-by":"publisher","first-page":"18781","DOI":"10.1074\/jbc.M112.345793","volume":"287","author":"M Fujikawa","year":"2012","unstructured":"Fujikawa M, et al. Assessing actual contribution of IF1, inhibitor of mitochondrial FoF1, to ATP homeostasis, cell growth, mitochondrial morphology, and cell viability. J Biol Chem. 2012;287(22):18781\u20137. doi: 10.1074\/jbc.M112.345793 .","journal-title":"J Biol Chem"},{"issue":"1","key":"430_CR19","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/0014-5793(87)81466-7","volume":"213","author":"F Guerrieri","year":"1987","unstructured":"Guerrieri F, et al. Regulatory role of the ATPase inhibitor protein on proton conduction by mitochondrial H\u2009+\u2009\u2212ATPase complex. FEBS Lett. 1987;213(1):67\u201372. doi: 10.1016\/0014-5793(87)81466-7 .","journal-title":"FEBS Lett"},{"issue":"1","key":"430_CR20","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/BF02110338","volume":"27","author":"E Vazquez-Contreras","year":"1995","unstructured":"Vazquez-Contreras E, Vazquez-Laslop N, Dreyfus G. The native F0F1-inhibitor protein complex from beef heart mitochondria and its reconstitution in liposomes. J Bioenerg Biomembr. 1995;27(1):109\u201316. doi: 10.1007\/BF02110338 .","journal-title":"J Bioenerg Biomembr"},{"issue":"33","key":"430_CR21","doi-asserted-by":"publisher","first-page":"25308","DOI":"10.1074\/jbc.M110.146480","volume":"285","author":"L Sanchez-Cenizo","year":"2010","unstructured":"Sanchez-Cenizo L, et al. Up-regulation of the ATPase inhibitory factor 1 (IF1) of the mitochondrial H\u2009+\u2009\u2212ATP synthase in human tumors mediates the metabolic shift of cancer cells to a Warburg phenotype. J Biol Chem. 2010;285(33):25308\u201313. doi: 10.1074\/jbc.M110.146480 .","journal-title":"J Biol Chem"},{"issue":"1\u20132","key":"430_CR22","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/0014-5793(89)81725-9","volume":"256","author":"AM Das","year":"1989","unstructured":"Das AM, Harris DA. Reversible modulation of the mitochondrial ATP synthase with energy demand in cultured rat cardiomyocytes. FEBS Lett. 1989;256(1\u20132):97\u2013100. doi: 10.1016\/0014-5793(89)81725-9 .","journal-title":"FEBS Lett"},{"issue":"1 Pt 2","key":"430_CR23","first-page":"H90","volume":"274","author":"DW Green","year":"1998","unstructured":"Green DW, et al. Preconditioning in rat hearts is independent of mitochondrial F1F0 ATPase inhibition. Am J Physiol. 1998;274(1 Pt 2):H90\u20137.","journal-title":"Am J Physiol"},{"issue":"1\u20132","key":"430_CR24","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1023\/A:1026558922596","volume":"215","author":"F Bosetti","year":"2000","unstructured":"Bosetti F, et al. Myocardial ischemic preconditioning and mitochondrial F1F0-ATPase activity. Mol Cell Biochem. 2000;215(1\u20132):31\u20137. doi: 10.1023\/A:1026558922596 .","journal-title":"Mol Cell Biochem"},{"issue":"2","key":"430_CR25","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/00041433-200004000-00004","volume":"11","author":"B Trigatti","year":"2000","unstructured":"Trigatti B, Rigotti A, Krieger M. The role of the high-density lipoprotein receptor SR-BI in cholesterol metabolism. Curr Opin Lipidol. 2000;11(2):123\u201331.","journal-title":"Curr Opin Lipidol"},{"issue":"1","key":"430_CR26","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.atherosclerosis.2014.11.017","volume":"238","author":"LO Martinez","year":"2015","unstructured":"Martinez LO, et al. Ecto-F1-ATPase\/P2Y pathways in metabolic and vascular functions of high density lipoproteins. Atherosclerosis. 2015;238(1):89\u2013100. doi: 10.1016\/j.atherosclerosis.2014.11.017 .","journal-title":"Atherosclerosis"},{"issue":"4","key":"430_CR27","doi-asserted-by":"publisher","first-page":"e2600","DOI":"10.1097\/md.0000000000002600","volume":"95","author":"JJ Li","year":"2016","unstructured":"Li JJ, et al. Large HDL subfraction but Not HDL-C is closely linked with risk factors, coronary severity and outcomes in a cohort of nontreated patients with stable coronary artery disease: a prospective observational study. Medicine (Baltimore). 2016;95(4):e2600. doi: 10.1097\/md.0000000000002600 .","journal-title":"Medicine (Baltimore)"},{"issue":"25","key":"430_CR28","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.2174\/0929867321666140414103455","volume":"21","author":"M Rizzo","year":"2014","unstructured":"Rizzo M, et al. Subfractions and subpopulations of HDL: an update. Curr Med Chem. 2014;21(25):2881\u201391. doi: 10.2174\/0929867321666140414103455 .","journal-title":"Curr Med Chem"},{"issue":"3","key":"430_CR29","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.beem.2013.11.002","volume":"28","author":"PP Toth","year":"2014","unstructured":"Toth PP, et al. Should low high-density lipoprotein cholesterol (HDL-C) be treated? Best Pract Res Clin Endocrinol Metab. 2014;28(3):353\u201368. doi: 10.1016\/j.beem.2013.11.002 .","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"12","key":"430_CR30","doi-asserted-by":"publisher","first-page":"6656","DOI":"10.1073\/pnas.131067798","volume":"98","author":"TL Moser","year":"2001","unstructured":"Moser TL, et al. Endothelial cell surface F1-F0 ATP synthase is active in ATP synthesis and is inhibited by angiostatin. Proc Natl Acad Sci U S A. 2001;98(12):6656\u201361. doi: 10.1073\/pnas.131067798 .","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"430_CR31","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1074\/jbc.M113.528026","volume":"289","author":"A Villarejo","year":"2014","unstructured":"Villarejo A, et al. Differential role of Snail1 and Snail2 zinc fingers in E-cadherin repression and epithelial to mesenchymal transition. J Biol Chem. 2014;289(2):930\u201341. doi: 10.1074\/jbc.M113.528026 .","journal-title":"J Biol Chem"},{"issue":"23","key":"430_CR32","doi-asserted-by":"publisher","first-page":"8184","DOI":"10.1128\/mcb.21.23.8184-8188.2001","volume":"21","author":"EA Carver","year":"2001","unstructured":"Carver EA, et al. The mouse snail gene encodes a key regulator of the epithelial-mesenchymal transition. Mol Cell Biol. 2001;21(23):8184\u20138. doi: 10.1128\/mcb.21.23.8184-8188.2001 .","journal-title":"Mol Cell Biol"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-017-0430-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T05:58:37Z","timestamp":1498370317000},"score":1,"resource":{"primary":{"URL":"http:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-017-0430-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,7]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["430"],"URL":"https:\/\/doi.org\/10.1186\/s12944-017-0430-9","relation":{},"ISSN":["1476-511X"],"issn-type":[{"type":"electronic","value":"1476-511X"}],"subject":[],"published":{"date-parts":[[2017,2,7]]},"article-number":"35"}}